SEC 13F Intelligence

Polaris Capital Management, LLC / ALXN

Polaris Capital Management, LLC’s Alexion Pharmaceuticals Inc Position

Does Polaris Capital Management, LLC own Alexion Pharmaceuticals Inc (ALXN)? Not currently — the last reported position was 306.9K shares worth $53M in Q1 2021; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$53M
Q1 2021
Shares
306.9K
% of Portfolio
+1.73%
Quarters Held
3
position exited

Position History ALXN

Reported value by quarter
Q3 ’20: $39MQ3 ’20Q4 ’20: $54MQ4 ’20Q1 ’21: $53MQ1 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2021306.9K$53M+1.73%
Q4 2020342.9K$54M+2.01%
Q3 2020341.4K$39M+1.93%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Polaris Capital Management, LLC’s full portfolio or all institutional holders of ALXN.